Cargando…

Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease

Acetylcholinesterase (AChE) plays an important role in Alzheimer's disease (AD). The excessive activity of AChE causes various neuronal problems, particularly dementia and neuronal cell deaths. Generally, anti-AChE drugs induce some serious neuronal side effects in humans. Therefore, this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijayakumar, Subramaniyan, Manogar, Palani, Prabhu, Srinivasan, Sanjeevkumar Singh, Ram Avadhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308024/ https://www.ncbi.nlm.nih.gov/pubmed/30595949 http://dx.doi.org/10.1016/j.jpha.2017.07.006

Ejemplares similares

In silico prediction of monovalent and chimeric tetravalent vaccines for prevention and treatment of dengue fever
por: Subramaniyan, Vijayakumar, et al.
Publicado: (2018)

Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches
por: Srinivasan, Prabhu, et al.
Publicado: (2018)

Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023)

Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies
por: Budryn, Grażyna, et al.
Publicado: (2022)

Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer's Disorders Using Molecular Docking and Molecular Dynamics Simulation
por: Seniya, Chandrabhan, et al.
Publicado: (2014)

Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors
por: Sonmez, Fatih, et al.
Publicado: (2017)

Absorption and Excretion of Antipyrine
Publicado: (1888)

Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
por: Prabhu, Srinivasan, et al.
Publicado: (2022)

Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation
por: Fang, Jiansong, et al.
Publicado: (2014)

A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease
por: Peitzika, Stergiani-Chrysovalanti, et al.
Publicado: (2023)

Evaluation of Activity of Sesquiterpene Lactones and Chicory Extracts as Acetylcholinesterase Inhibitors Assayed in Calorimetric and Docking Simulation Studies
por: Jaśkiewicz, Andrzej, et al.
Publicado: (2022)

Study on the active ingredients of Shenghui decoction inhibiting acetylcholinesterase based on molecular docking and molecular dynamics simulation
por: Li, Zefei, et al.
Publicado: (2023)

The protein flexibility in receptor-ligand docking simulations
por: Tristram, Frank
Publicado: (2010)

Diet in Disease: X.—Digestion—Absorption—Excretion
por: Hart, Ernest
Publicado: (1892)

Acetylcholinesterase-Inhibiting Activity of Salicylanilide N-Alkylcarbamates and Their Molecular Docking
por: Imramovsky, Ales, et al.
Publicado: (2012)

Altered Levels of Acetylcholinesterase in Alzheimer Plasma
por: García-Ayllón, María-Salud, et al.
Publicado: (2010)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
por: El-Hussieny, Marwa, et al.
Publicado: (2023)

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
por: Jabir, Nasimudeen R., et al.
Publicado: (2021)

Observations on the Absorption, Excretion, Diffusion, and Acetylation of Sulfadiazine in Man
por: Sadusk, Joseph F., et al.
Publicado: (1941)

Observations on the Absorption, Excretion, Diffusion, and Acetylation of Sulfathiazole in Man
por: Sadusk, Joseph F., et al.
Publicado: (1940)

Absorption, distribution, metabolism and excretion of molidustat in healthy participants
por: Lentini, Silvia, et al.
Publicado: (2020)

Absorption, metabolism and excretion of opicapone in human healthy volunteers
por: Loureiro, Ana I., et al.
Publicado: (2022)

In vitro acetylcholinesterase inhibition by psoralen using molecular docking and enzymatic studies
por: Somani, Gauresh, et al.
Publicado: (2015)

Unfolding the Antibacterial Activity and Acetylcholinesterase Inhibition Potential of Benzofuran-Triazole Hybrids: Synthesis, Antibacterial, Acetylcholinesterase Inhibition, and Molecular Docking Studies
por: Saeed, Sadaf, et al.
Publicado: (2023)

Exploring Medicinal Herbs’ Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer’s Disease Treatment
por: Farihi, Ayoub, et al.
Publicado: (2023)

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
por: Toiber, Debra, et al.
Publicado: (2008)

AQDnet: Deep Neural Network for Protein–Ligand Docking Simulation
por: Shiota, Koji, et al.
Publicado: (2023)

Chemical profile of Lippia thymoides, evaluation of the acetylcholinesterase inhibitory activity of its essential oil, and molecular docking and molecular dynamics simulations
por: Silva, Sebastião Gomes, et al.
Publicado: (2019)

Exploring the Binding Pattern of Geraniol with Acetylcholinesterase through In Silico Docking, Molecular Dynamics Simulation, and In Vitro Enzyme Inhibition Kinetics Studies
por: Iqbal, Danish, et al.
Publicado: (2021)

Comment on Budryn et al. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies. Nutrients 2022, 14, 2476
por: Zarguan, Ilham, et al.
Publicado: (2022)

Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
por: Chen, Yu‐Luan, et al.
Publicado: (2016)

Lycopene: A Critical Review of Digestion, Absorption, Metabolism, and Excretion
por: Arballo, Joseph, et al.
Publicado: (2021)

Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans
por: Nussbaum, Jesse C., et al.
Publicado: (2022)

Investigation of Intestinal Absorption and Excretion of Paracetamol in Streptozotocin-Induced Hyperglycemia
por: Mészáros, Petra, et al.
Publicado: (2022)

Probing the origins of human acetylcholinesterase inhibition via QSAR modeling and molecular docking
por: Simeon, Saw, et al.
Publicado: (2016)

Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database
por: Doytchinova, Irini, et al.
Publicado: (2018)

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease
por: Yusufzai, Samina Khan, et al.
Publicado: (2018)

Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors
por: Ferris, Steven H, et al.
Publicado: (2013)

The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
por: Vecchio, Immacolata, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_atel3ob3sai85kqt1g2dklnc6o